Cooper E H, Turner R, Steele L, Neville A M, Mackay A M
Br J Cancer. 1975 Jan;31(1):111-7. doi: 10.1038/bjc.1975.13.
The evolution of metastatic colorectal cancer in patients who have had surgical treatment for a primary lesion was studied in relation the progressive changes in the blood levels of carcinembryonic antigen (CEA), to gamma glutamyl transpeptidase (GGT) and routine liver function tests (LFTs). Involvement of the liver could ofter be reliably predicted many weeks in advance of clinical diagnosis while metastases to other sites were less likely to be detected early by this test. The association of the extent of disease with the patterns of biochemical changes is discussed with reference to several illustrative examples.
对已接受原发性病变手术治疗的转移性结直肠癌患者的病情演变进行了研究,研究内容涉及癌胚抗原(CEA)、γ-谷氨酰转肽酶(GGT)的血液水平以及常规肝功能检查(LFTs)的渐进性变化。在临床诊断前数周,通常能够可靠地预测肝脏是否受累,而通过该检测早期发现转移至其他部位的可能性较小。结合几个实例讨论了疾病程度与生化变化模式之间的关联。